Novel markers, a payer's perspective: Commissioning a new service

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue SUPPL. 242, 2010, Pages 103-108

  Price, Christopher P ^a,b   Martin, Les ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b North Lancashire Primary Care Trust   (United Kingdom)

Author keywords

Disruptive innovation; Evidence based practice; Laboratory medicine; Outcomes; Transformational change; Value

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL LABORATORY; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EVIDENCE BASED PRACTICE; HEALTH CARE NEED; HEALTH SERVICE; HUMAN; PATIENT CARE; PRIORITY JOURNAL; PROBLEM SOLVING; REVIEW; ARTICLE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; ECONOMICS; FINANCIAL MANAGEMENT; LABORATORY; MASS COMMUNICATION; MEDICAL TECHNOLOGY; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; STANDARD; STATISTICS; UNITED KINGDOM;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; CONTRACT SERVICES; DIFFUSION OF INNOVATION; EVIDENCE-BASED PRACTICE; GREAT BRITAIN; HUMANS; LABORATORIES; LABORATORY TECHNIQUES AND PROCEDURES; MODELS, ORGANIZATIONAL; OUTCOME ASSESSMENT (HEALTH CARE); TECHNOLOGY, MEDICAL;

EID: 77953156154     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2010.493420     Document Type: Review

References (29)

1. st century. National Academy Press, Washington DC, 2001. pp. 337.
2. Christensen CM, Bohmer R, Kenagy J. Will disruptive innovations cure health care? Harv Bus Rev. 2000;78:102-12.
3. Sackett DL, Haynes RB. The architecture of diagnostic research. BMJ 2002;324:539-41.
4. Christensen CM, Grossman JH, Hwang J. The innovator' s prescription. A disruptive solution for health care. New York, McGraw Hill, 2009. pp. 441.
5. Economist Intelligence Unit. Doctor Innovation. Shaking up the Health System. Economist Intelligence Unit, London, New York, Hong Kong; 2009.
6. National Academy of Engineering and Institute of Medicine. In: Reid PP, Compton WD, Grossman JH, Fanjiang G, editors. Building a better delivery system. National Academy Press, Washington; 2005. pp. 262.
7. National Institute of Biomedical Imaging and Bioengineering/National Heart, Lung and Blood Institute/National Science Foundation Workshop Faculty (eds Price CP and Kricka LJ). Improving healthcare accessibility through point-of-care technologies. Clin Chem 2007;53:1665-75.
8. Balk EM, Ioannidis JP, Salem D, Chew PW, Lau J. Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis. Ann Emerg Med. 2001;37:478-94. (Pubitemid 32417573)
9. Hobbs FD, Delaney BC, Fitzmaurice DA, Wilson S, Hyde CJ, Thorpe GH, et al. A review of near patient testing in primary care. Health Technol Assess 1997;1(5):1-230.
10. National Academy for Clinical Biochemistry. Laboratory Medicine Practice Guidelines Evidence-Based Practice for Point-of-Care Testing (Ed Nichols JH). Accessed at http://www.aacc.org/members/nacb/LMPG/OnlineGuide/ PublishedGuidelines/poct/Pages/poctpdf.aspx on November 17th 2009.
11. Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991;11:88-94.
12. Price CP. Evidence-based laboratory medicine: Supporting decision-making. Clin Chem 2000;46:1041-50.
13. Price CP, Christenson RH (eds). Evidence-based laboratory Medicine: principles, practice and outcomes. Second Edition. Washington DC, AACC Press, 2007. pp. 545.
14. Price CP, Lozar Glenn J, Christenson RH. Applying evidence-based laboratory medicine: A step-by-step guide. Washington DC, AACC Press, 2009. pp. 260.
15. Mankoff SP, Brander C, Ferrone S, Marincola FM. Lost in translation: Obstacles to translational medicine. J Translational Med 2004;2:14.
16. Glasziou P, Del Mar. C, Salisbury J. Evidence-based practice workbook. Second edition. Blackwell Publishing, Oxford 2007. pp. 202.
17. Woodin, J. Healthcare commissioning and contracting. In Walshe K, Smith J (eds). Healthcare management. Open University Press, Maidenhead, 2006. pp. 525.
18. th 2009.
19. Price CP, Jones RG. The challenges in commissioning laboratory medicine (pathology) services. Journal of Management and Marketing in Healthcare. 2008;1:166-78.
20. Mannion R. General practitioner commissioning in the English National Health Service: Continuity, change, and future challenges. Int J Health Serv. 2008;38:717-30.
21. Department of Health. Health reform in England: Update and commissioning framework; annex the commis sioning framework. 2006. Accessed at http://www.dh.gov. uk/prod-consum-dh/groups/dh-digitalassets/@dh/@en/documents/ digitalasset/dh-4137230pdf on November 17th 2009.
22. Department of Health. Commissioning a patient-led NHS. 2005. Accessed at http://www.dh.gov. uk/en/Publication statistics/Publications/ PublicationsPolicyAndGuidance/DH-4116716 on November 17th 2009.
23. th 2009.
24. Lord Carter of Coles. Report of the second phase of the review of NHS pathology services in England 2008. Accessed at http://www.dh.gov. uk/en/Healthcare/Pathology/DH-075531 on November 17th 2009.
25. Wilson E, Sussex J, Macleod C, Fordham R. Prioritizing health technologies in a primary care trust. J Health Serv Res Policy. 2007;12:80-5.
26. NHS Choices, Your Health, Your Choices. Map of Medicine: Heart Failure - suspected. Accessed at http://healthguides.mapofmedicine.com/choices/map/heart- failure1.html on November 17th 2009.
27. Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 2009;13(32):1-232.
28. Airoldi M, Bevan G, Morton A, Oliveira M, Smith J. Requisite models for strategic commissioning: the example of type 1 diabetes. Health Care Manag Sci. 2008;11:89-110.
29. Charlton R. Practice-based commissioning: implications for secondary care. Clin Med. 2008;8:61-4.